Skip to main content
. 2021 Aug 18;4(8):e2121505. doi: 10.1001/jamanetworkopen.2021.21505

Table 1. Baseline Characteristics of Study Participants.

Characteristic Participants, No. (%) (N = 19 213)a
Total intervention group (n = 9705) Total control group (n = 9508) Intervention group by breast density Control group by breast density
Dense (n = 5797) Nondense (n = 3908)b Dense (n = 5593)b Nondense (n = 3915)b
Age, mean (SD), y 44.5 (2.9) 44.6 (2.9) 44.5 (2.9) 44.7 (2.9) 44.5 (2.9) 44.6 (2.9)
Ever undergo breast cancer screening
No 1687 (17.4) 1895 (19.9) 995 (17.2) 692 (17.7) 1094 (19.6) 801 (20.5)
Yes 8018 (82.6) 7613 (80.1) 4802 (82.8) 3216 (82.3) 4499 (80.4) 3114 (79.5)
Time since most recent breast cancer screening, mo
<12 716 (8.9) 681 (9.0) 441 (9.2) 275 (8.6) 424 (9.4) 257 (8.3)
12-24 2942 (36.7) 2773 (36.4) 1759 (36.6) 1183 (36.8) 1620 (36.0) 1153 (37.0)
25-36 2916 (36.4) 2806 (36.9) 1710 (35.6) 1206 (37.5) 1667 (37.1) 1139 (36.6)
>36 1391 (17.4) 1308 (17.2) 859 (17.9) 532 (16.5) 762 (16.9) 546 (17.5)
Unknown or data missing 53 (0.7) 45 (0.6) 33 (0.7) 20 (0.6) 26 (0.6) 19 (0.6)
Method of most recent breast cancer screening
Mammography
No 2342 (29.2) 2191 (28.8) 1419 (29.6) 923 (28.7) 1308 (29.1) 883 (28.4)
Yes 5676 (70.8) 5422 (71.2) 3383 (70.5) 2293 (71.3) 3191 (70.9) 2231 (71.6)
Ultrasonography
No 6406 (79.9) 6221 (81.7) 3800 (79.1) 2606 (81.0) 3647 (81.1) 2574 (82.7)
Yes 1612 (20.1) 1392 (18.3) 1002 (20.9) 610 (19.0) 852 (18.9) 540 (17.3)
Clinical breast examination
No 356 (4.4) 332 (4.4) 215 (4.5) 141 (4.4) 194 (4.3) 138 (4.4)
Yes 7662 (95.6) 7281 (95.6) 4587 (95.5) 3075 (95.6) 4305 (95.7) 2976 (95.6)
Age at menarche, y
≤9 25 (0.3) 25 (0.3) 12 (0.2) 13 (0.3) 9 (0.2) 16 (0.4)
10-15 9559 (98.5) 9383 (98.7) 5709 (98.5) 3850 (98.5) 5517 (98.6) 3866 (98.8)
≥16 121 (1.3) 100 (1.1) 76 (1.3) 45 (1.2) 67 (1.2) 33 (0.8)
Menopausal status
Premenopausal 7353 (75.8) 7285 (76.6) 4502 (77.7) 2851 (73.0) 4399 (78.7) 2886 (73.7)
Perimenopausal 1699 (17.5) 1615 (17.0) 948 (16.4) 751 (19.2) 876 (15.7) 739 (18.9)
Postmenopausal 652 (6.7) 603 (6.3) 347 (6.0) 305 (7.8) 315 (5.6) 288 (7.4)
Unknown or data missing 1 (<0.1) 5 (<0.1) 0 1 (<0.1) 3 (<0.1) 2 (<0.1)
Pregnancies, No.
0 813 (8.4) 742 (7.8) 606 (10.5) 207 (5.3) 520 (9.3) 222 (5.7)
1 1192 (12.3) 1170 (12.3) 768 (13.3) 424 (36.5) 762 (13.6) 408 (10.4)
2 3659 (37.7) 3603 (37.9) 2233 (38.5) 1426 (36.5) 2154 (38.5) 1449 (37.0)
3-4 3425 (35.3) 3328 (35.0) 1875 (38.5) 1550 (39.7) 1757 (31.4) 1571 (40.1)
5-10 372 (3.8) 400 (4.2) 159 (2.7) 213 (5.5) 212 (3.8) 188 (4.8)
Unknown or data missing 244 (2.5) 265 (2.8) 156 (2.7) 88 (2.3) 188 (3.4) 77 (2.0)
Pregnancies delivered, No.
Nulliparous 130 (1.5) 124 (1.5) 96 (1.9) 34 (0.9) 85 (1.7) 39 (1.1)
1 1427 (16.5) 1423 (16.7) 924 (18.4) 503 (13.9) 929 (19.0) 494 (13.7)
2 4499 (52.0) 4448 (52.3) 2690 (18.4) 1809 (50.1) 2625 (53.7) 1823 (50.4)
3 2270 (26.3) 2202 (25.9) 1191 (23.7) 1079 (29.9) 1113 (22.8) 1089 (30.1)
4-8 291 (3.4) 257 (3.0) 118 (2.3) 173 (4.8) 105 (2.2) 152 (4.2)
Unknown or data missing 31 (0.4) 47 (0.6) 16 (2.3) 15 (0.4) 28 (0.6) 19 (0.5)
Age at first parturition, y
<20 102 (1.2) 80 (0.9) 58 (1.2) 44 (1.2) 44 (0.9) 36 (1.0)
20-24 1626 (18.8) 1470 (17.3) 897 (17.8) 729 (20.2) 783 (16.0) 687 (19.0)
25-29 3245 (37.5) 3184 (37.5) 1901 (37.8) 1344 (37.2) 1811 (37.1) 1373 (38.0)
30-39 1882 (21.8) 2022 (23.8) 1132 (22.5) 750 (20.8) 1239 (25.4) 783 (21.7)
40-49 48 (0.6) 47 (0.6) 36 (0.7) 12 (0.3) 27 (0.6) 20 (0.6)
Unknown or data missing 1745 (20.2) 1698 (20.0) 1011 (20.1) 734 (20.3) 981 (20.1) 717 (19.8)
Ever breastfed children
Yes 7754 (90.9) 7570 (90.4) 4507 (91.1) 3247 (90.6) 4338 (90.4) 3232 (90.4)
No 758 (8.9) 792 (9.5) 428 (8.7) 330 (9.2) 455 (9.5) 337 (9.4)
Unknown or data missing 21 (0.3) 16 (0.2) 15 (0.3) 6 (0.2) 8 (0.2) 8 (0.2)
First-degree female relatives with breast cancer, No.
0 9214 (94.9) 9024 (94.9) 5503 (94.9) 3711 (95.0) 5299 (94.7) 3725 (95.2)
1 485 (5.0) 477 (5.0) 291 (5.0) 194 (5.0) 289 (5.2) 188 (4.8)
>1 6 (<0.1) 7 (<0.1) 3 (<0.1) 3 (<0.1) 5 (<0.1) 2 (<0.1)
Ever had breast surgery 227 (1.2) 214 (1.1) 170 (1.8) 57 (0.6) 140 (1.5) 74 (0.8)
Ever had benign neoplasm 154 (0.8) 143 (0.7) 121 (1.3) 33 (0.3) 97 (1.0) 46 (0.5)
Ever had breast inflammation 71 (0.4) 70 (0.4) 46 (0.5) 25 (0.3) 45 (0.5) 25 (0.3)
a

Percentages might not total 100% because of rounding.

b

The 2 least dense categories (almost entirely fatty and scattered fibroglandular tissues) are referred to as nondense, conventionally, the 2 most dense categories (heterogeneously dense and extremely dense) are referred to as dense.